The role and impact of Del(5q) and TP53 mutations on haematopoietic stem and progenitor cells during the progression of Myelodysplastic Syndrome to Acute Myeloid Leukaemia

The role and impact of Del(5q) and TP53 mutations on haematopoietic stem and progenitor cells during the progression of Myelodysplastic Syndrome to Acute Myeloid Leukaemia

<p>Myelodysplastic Syndromes (MDS) are a heterogeneous group of haematological malignancies characterised by ineffective haematopoiesis and dysplastic bone marrow changes. Patients frequently progress to Acute Myeloid Leukaemia and this is associated with very poor clinical outcomes. This t...

書誌詳細
第一著者:	Doolittle, H
その他の著者:	Jacobsen, S
フォーマット:	学位論文
出版事項:	2017

類似資料

Characterising early human lympho-myeloid haematopoietic progenitors and their relationship with acute myeloid leukaemia stem cells
著者:: Aboukhalil, Z
出版事項: (2018)

TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome
著者:: Pimjai Niparuck, 等
出版事項: (2021-10-01)

TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia
著者:: Ramy Rahmé, 等
出版事項: (2023-04-01)

TP53-mutated myelodysplastic syndrome and acute myeloid leukemia: biology, current therapy, and future directions
著者:: Daver, NG, 等
出版事項: (2022)

Allogeneic haematopoietic stem cell transplantation with decitabine-containing preconditioning regimen in TP53-mutant myelodysplastic syndromes: A case study
著者:: Yuxin Wang, 等
出版事項: (2022-07-01)

NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).
著者:: Fidler, C, 等
出版事項: (2004)

TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA
著者:: Ugo Testa, 等
出版事項: (2023-06-01)

P1288: UNMANIPULATED PERIPHERAL HAPLOIDENTICAL HAEMATOPOIETIC STEM CELL TRANSPLANT IS AN EFFECTIVE CONSOLIDATIVE STRATEGY FOR HIGH-RISK ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASTIC SYNDROME
著者:: Fabio Serpenti, 等
出版事項: (2023-08-01)

Rare case of myelodysplastic syndrome with near-tetraploidy and TP53 mutation
著者:: Čolović Nataša, 等
出版事項: (2023-01-01)

Clinical outcomes and characteristics of patients with TP53-mutated myelodysplastic syndromes
著者:: Lijuan Zhang, 等
出版事項: (2023-12-01)

Immunohistochemical pattern of p53 is a measure of TP53 mutation burden and adverse clinical outcome in myelodysplastic syndromes and secondary acute myeloid leukemia
著者:: Kathy L. McGraw, 等
出版事項: (2016-08-01)

Emergence and evolution of TP53 mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide
著者:: Laurence Lodé, 等
出版事項: (2018-04-01)

Identification and characterisation of the haematopoietic stem/progenitor cells at risk for leukaemia development following radiation exposure
著者:: Verbiest, T
出版事項: (2016)

PB1913: SYNERGISTIC EFFECTS OF DECITABINE AND APR-246 IN TP53 P.248Q-MUTATED MYELODYSPLASTIC SYNDROME
著者:: Y. Fang, 等
出版事項: (2022-06-01)

Single-molecule DNA sequencing of acute myeloid leukemia and myelodysplastic syndromes with multiple TP53 alterations
著者:: Laurence Lodé, 等
出版事項: (2018-01-01)

Unravelling haematopoietic stem cell dysfunction in isolated Del(5q) myelodysplastic syndromes
著者:: Stenson, L
出版事項: (2015)

Synergistic effects of PRIMA-1Met (APR-246) and 5-azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia
著者:: Nabih Maslah, 等
出版事項: (2020-06-01)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
著者:: R Edlin, 等
出版事項: (2010-05-01)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
著者:: R Edlin, 等
出版事項: (2010-05-01)

Bladder Myeloid Sarcoma with TP53 mutated Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap syndrome: Response to Decitabine-Venetoclax regimen
著者:: Nikeeta Mandhan, 等
出版事項: (2022-01-01)

Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemia
著者:: Lu Bai, 等
出版事項: (2022-08-01)

Allogeneic Haematopoietic Stem Cell Transplantation for Chronic Myeloid Leukaemia in the Era of Tyrosine Kinase Inhibitors
著者:: Ahmet Emre Eskazan, 等
出版事項: (2018-08-01)

Clinical implications of subclonal TP53 mutations in acute myeloid leukemia
著者:: Katharina T. Prochazka, 等
出版事項: (2019-03-01)

TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies
著者:: Marianna B. Ruzinova, 等
出版事項: (2019-08-01)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
著者:: Boultwood, J, 等
出版事項: (2009)

Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia
著者:: Sitânia Chiesa, 等
出版事項: (2024-12-01)

Transformation of myelodysplastic syndrome (MDS) to acute myeloid leukaemia (AML)
著者:: Goh, Chermaine Yu Zhen
出版事項: (2021)

hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia.
著者:: Campbell, L, 等
出版事項: (2006)

TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?
著者:: Matteo Molica, 等
出版事項: (2021-02-01)

Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine.
著者:: Pierre Bories, 等
出版事項: (2020-01-01)

Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine
著者:: Pierre Bories, 等
出版事項: (2020-01-01)

TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
著者:: Haase, D, 等
出版事項: (2019)

To target the untargetable: elucidation of synergy of APR-246 and azacitidine in TP53 mutant myelodysplastic syndromes and acute myeloid leukemia
著者:: David A. Sallman
出版事項: (2020-06-01)

Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions
著者:: Shyam A. Patel, 等
出版事項: (2023-11-01)

Acute Lymphoblastic Leukaemia in the Youngest: Haematopoietic Stem Cell Transplantation and Beyond
著者:: Adriana Balduzzi, 等
出版事項: (2022-02-01)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
著者:: Boultwood, J, 等
出版事項: (2004)

INVESTIGATION OF THE IMPACT OF THE R248Q MUTATION IN THE TP53 GENE ON THE INTERACTION OF THE P53 PROTEIN WITH THE DRUG APR-246 IN ACUTE MYELOID LEUKEMIA
著者:: LMF Bertoline, 等
出版事項: (2024-10-01)

Recruiting TP53 to target chronic myeloid leukemia stem cells
著者:: Steven Grant
出版事項: (2020-05-01)

P471: POLO-LIKE KINASE 4 INHIBITION INDUCED ANTI-LEUKAEMIC EFFECTS THROUGH HISTONE MODIFICATION IN TP53 MUTATED ACUTE MYELOID LEUKAEMIA
著者:: Wing Lam, 等
出版事項: (2023-08-01)

What have we learned about TP53-mutated acute myeloid leukemia?
著者:: Moazzam Shahzad, 等
出版事項: (2024-11-01)